Has Israel Sokeye, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,098 in general payments to Israel Sokeye, MD across 59 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Israel Sokeye, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Israel Sokeye, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Israel Sokeye, MD

Child & Adolescent Psychiatry · Plymouth, MNNPI 1548428808

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 59 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Neuronetics, Inc. at 31.9% of the total. Reporting peaked in 2023 at $396 and has fallen 64.8% since, to $139 in 2025. Among child & adolescent psychiatry clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,098in general payments, 2019–2025

Across 59 payments — averaging $18.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Neuronetics, Inc.$350
Ironshore Pharmaceuticals Inc.$120
Tris Pharma Inc$112
Corium, LLC$109
Supernus Pharmaceuticals, Inc.$59
Lundbeck LLC$44
plus $304 from 13 others

What the payments were for

Food & beverage$1,098100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Neuronetics, Inc.	15	$350
Ironshore Pharmaceuticals Inc.	6	$120
Tris Pharma Inc	6	$112
Corium, LLC	8	$109
Supernus Pharmaceuticals, Inc.	3	$59
Lundbeck LLC	3	$44
Teva Pharmaceuticals USA, Inc.	2	$41
Sage Therapeutics, LLC	2	$38
Merck	2	$34
Vanda Pharmaceuticals Inc.	2	$32
Tempus AI, Inc	1	$29
Takeda Pharmaceuticals U.S.A., Inc.	2	$29
Collegium Pharmaceutical, Inc.	1	$15
Neurocrine Biosciences, Inc.	1	$15
AbbVie	1	$15
Idorsia Pharmaceuticals US Inc	1	$15
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$15
Alkermes, Inc.	1	$13
Vertical Pharmaceuticals, LLC	1	$12

How this compares

$1,098 in reported general payments places this provider in the 90th percentile of 21 child & adolescent psychiatry providers in Minnesota.

See all child & adolescent psychiatry providers in Minnesota →

Medicare billing

Part B allowed, 2024

$47,622

Medicare patients

Services billed

250

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
LatudaLurasidone Hcl	13	$30,269
Atomoxetine Hcl	23	$3,221
Divalproex Sodium	13	$2,408
Fluoxetine Hcl	39	$1,495
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	17	$1,143
Quetiapine Fumarate	50	$1,024
Clomipramine Hcl	34	$855
Ziprasidone Hcl	12	$800
Venlafaxine Hcl ErVenlafaxine Hcl	72	$756
Lorazepam	25	$705
Quetiapine Fumarate ErQuetiapine Fumarate	33	$693
Olanzapine	31	$679
Lamotrigine	49	$610
Bupropion XlBupropion Hcl	23	$609
Hydroxyzine Hcl	32	$523

Paid to pharmacies, not to this prescriber.

Other child & adolescent psychiatry in Plymouth

Joseph LeePlymouth$36
Peter KarachunskiMinneapolis$22K
Kim HoltmeierGolden Valley$5K
Sreelatha SpiekerMankato$854
Carl HansenSt Louis Park$396
Travis HansenMankato$358
Michael AdelmanBaxter$313
Lynda BargerGolden Valley$192
Tan NgoBrooklyn Park$119
Jonathan JensenMinneapolis$109

See the full list for Minnesota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →